drugset / Trial / NCT01260636

Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries

NCT01260636

Phase 3 Completed 120 enrolled Bracco Diagnostics, Inc
RandomizedCrossoverTriple-blindDiagnostic

Summary

To compare two gadolinium contrast agents in terms of global paired diagnostic preference (primary endpoint) for the assessment of contrast-enhanced MR Angiography of the carotid, renal/abdominal and peripheral arteries

Timeline

Start
2009-09
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadobenate dimeglumine Diagnostic / imaging agent 0.1 unknown
Comparator Gadopentetate dimeglumine Diagnostic / imaging agent 0.2 unknown

Indications